Skip to main content
OpenTrials
Completed

NCT Number: NCT01527799

Exercise Capacity in Pediatric Sickle Cell Anemia

The purpose of this study is to use comprehensive exercise testing to examine causes of exercise limitation in children and young adults with sickle cell anemia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–21 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

About this study

Although the burden of sickle cell anemia (SCA) on affected individuals is significant, few studies have examined the influence of having SCA on such measures of physical function as exercise capacity. Moreover, the physiologic basis of poor physical functioning in children with SCA is unknown and has not been studied extensively. The purpose of this proposal is to use cardiopulmonary exercise testing (CPET) to gain a comprehensive understanding of exercise capacity, as a measure of physical function, in children and young adults with SCA. The specific aims of this project are to: 1) Measure peak oxygen consumption (VO2), the reference standard for exercise capacity, in children and young adults with SCA classified by primary pathophysiologic contributor to their decreased exercise capacity, and 2) Examine the acute inflammatory response, measured by an increase in soluble vascular cell adhesion molecule (sVCAM) activity, in subjects undergoing CPET. These aims will be performed in 60 subjects with SCA and 30 matched controls without SCA. In a secondary analysis, we will also study the impact of baseline exercise capacity and the inflammatory response to exercise on short and long-term disease related morbidity. This study is essential because it will address several areas of exercise capacity, including the physiologic contributors to exercise limitation that remain fundamental knowledge gaps in SCA.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 10 to 21 years old; AND
  • Hb SS or S-β0 thalassemia disease, confirmed by hemoglobin analysis

Exclusion criteria

  • inability to perform maximal testing due to physical limitation (e.g. stroke or avascular necrosis); OR
  • history of exercise-induced syncope or arrhythmias. Subjects will wait at least 2 weeks following any vaso-occlusive pain episode and 12 weeks following any disease-related complication requiring transfusion support. Individuals on hydroxyurea will be eligible. A total of 30 controls without SCA or sickle cell trait will be matched for age, sex and race and recruited from the siblings, friends or relatives of subjects enrolled on this study

Treatment and study plan

Primary outcomes

  1. VO2 max on cardiopulmonary exercise test

    Time frame: Baseline

Secondary outcomes

  1. Skin fold measurements to detemine percent body fat

    Time frame: Baseline

  2. All patient reported pain episodes

    Time frame: Every 2 months up to 2 years after baseline

  3. Change in secondary biomarkers in response to exercise test

    Time frame: Baseline (Pre-exercise) and Post-exercise

  4. Change in VCAM level in response to exercise testing

    Time frame: Baseline (pre-exercise) and Post-exercise

Sponsors and collaborators

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia

Important dates

Study start
2009
Primary completion
2015
Study completion
2015
First posted
Feb 7, 2012
Registry last updated
Feb 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.